Literature DB >> 10393611

In vivo brain myo-inositol levels in children with Down syndrome.

G T Berry1, Z J Wang, S F Dreha, B M Finucane, R A Zimmerman.   

Abstract

The Na+/myo-inositol cotransporter (SLC5A3) gene, located on the long arm of human chromosome 21, may play a key role in osmoregulation including the regulation of levels of the "idiogenic osmole," myo-inositol, in brain cells. To determine whether the levels of myo-inositol are increased in the basal ganglia of children with Down syndrome, we performed in vivo brain hydrogen 1-nuclear magnetic resonance or 1H-magnetic resonance spectroscopy and measured plasma osmolality in a cohort of children with trisomy 21. Myo-inositol is elevated in the corpus striatum of infants and children with Down syndrome, even in the absence of hypertonic stress.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393611     DOI: 10.1016/s0022-3476(99)70334-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

1.  Association of Myoinositol Transporters with Schizophrenia and Bipolar Disorder: Evidence from Human and Animal Studies.

Authors:  Marquis P Vawter; Abdul Rezzak Hamzeh; Edgar Muradyan; Olivier Civelli; Geoffrey W Abbott; Amal Alachkar
Journal:  Mol Neuropsychiatry       Date:  2019-08-08

Review 2.  Ion channel-transporter interactions.

Authors:  Daniel L Neverisky; Geoffrey W Abbott
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-04-20       Impact factor: 8.250

3.  Knockdown of Myo-Inositol Transporter SMIT1 Normalizes Cholinergic and Glutamatergic Function in an Immortalized Cell Line Established from the Cerebral Cortex of a Trisomy 16 Fetal Mouse, an Animal Model of Human Trisomy 21 (Down Syndrome).

Authors:  Ana María Cárdenas; Paola Fernández-Olivares; Ignacio Díaz-Franulic; Arlek M González-Jamett; Takeshi Shimahara; Juan Segura-Aguilar; Raúl Caviedes; Pablo Caviedes
Journal:  Neurotox Res       Date:  2017-07-10       Impact factor: 3.911

4.  Identification of a mammalian H(+)-myo-inositol symporter expressed predominantly in the brain.

Authors:  M Uldry; M Ibberson; J D Horisberger; J Y Chatton; B M Riederer; B Thorens
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

5.  Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome.

Authors:  Andreana P Haley; Mitzi M Gonzales; Takashi Tarumi; Steven C Miles; Katayoon Goudarzi; Hirofumi Tanaka
Journal:  Metab Brain Dis       Date:  2010-11-10       Impact factor: 3.584

6.  Osmoregulatory inositol transporter SMIT1 modulates electrical activity by adjusting PI(4,5)P2 levels.

Authors:  Gucan Dai; Haijie Yu; Martin Kruse; Alexis Traynor-Kaplan; Bertil Hille
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-23       Impact factor: 11.205

Review 7.  Molecular genetic analysis of Down syndrome.

Authors:  David Patterson
Journal:  Hum Genet       Date:  2009-06-13       Impact factor: 4.132

8.  Identification of a mutation associated with fatal Foal Immunodeficiency Syndrome in the Fell and Dales pony.

Authors:  Laura Y Fox-Clipsham; Stuart D Carter; Ian Goodhead; Neil Hall; Derek C Knottenbelt; Paul D F May; William E Ollier; June E Swinburne
Journal:  PLoS Genet       Date:  2011-07-07       Impact factor: 5.917

Review 9.  Metabolic and Vascular Imaging Biomarkers in Down Syndrome Provide Unique Insights Into Brain Aging and Alzheimer Disease Pathogenesis.

Authors:  Elizabeth Head; David K Powell; Frederick A Schmitt
Journal:  Front Aging Neurosci       Date:  2018-06-21       Impact factor: 5.750

10.  Brain changes in long-term zen meditators using proton magnetic resonance spectroscopy and diffusion tensor imaging: a controlled study.

Authors:  Nicolás Fayed; Yolanda Lopez Del Hoyo; Eva Andres; Antoni Serrano-Blanco; Juan Bellón; Keyla Aguilar; Ausias Cebolla; Javier Garcia-Campayo
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.